The Valley Desk

NCT01711554 · Interventional trial

Lenalidomide and Dinutuximab With or Without Isotretinoin in Treating Younger Patients With Refractory or Recurrent Neuroblastoma

Overall registry status Active not recruiting

Phase 1

Conditions Recurrent Neuroblastoma, Refractory Neuroblastoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov